TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer.

Quoc Thang PhamDaiki TaniyamaShintaro AkabaneKenji HaradaTakashi BabasakiYohei SekinoTetsuraro HayashiNaoya SakamotoKazuhiro SentaniNaohide OueWataru Yasui

Published in: Cancer reports (Hoboken, N.J.) (2021)

Our results indicate that TDO2 might take an essential part in BC progression and could be a potential marker for targeted therapy in BC.

Keyphrases